5,8-Dioxa-2,11-diazadodecanedioic acid, bis(1,1-dimethylethyl) ester, 97%, 1g

3-([2,2'-Bipyridin]-5-yl)-2-aminopropanoic acid hydrochloride, 97.0%, 25mg

(S)-2,3,4,6,7,11b-hexahydro-1H-pyrazino[2,1-a]isoquinoline dihydrochloride, 97%, 100mg

(R)-2-Amino-2-(3-chlorophenyl)ethanol, 95.0%, 5g

6-BROMO-8-METHOXY-[1,2,4]TRIAZOLO[1,5-A]PYRAZINE, 95%, 100mg

Capilar de punto de fusión ROTILABO®, 100 Unidad(es)

3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 95.0%, 1g

N-(4-Methyl-benzylidene)-benzenesulfonamide, 98%, 1g

1-(3-Methoxy-5-(trifluoromethyl)pyridin-2-yl)ethanone, 97%, 100mg

6-BROMO-3-CYCLOPROPYL-1H-INDAZOLE, 95%, 100mg

Tubo de ensayo DURAN® con borde rebordeado, 40 ml, 100 Unidad(es)

2-(4-Iodophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

4-(Methoxymethyl)pyridine, 95%, 5g